DK0426785T3 - Præparater og fremgangsmåder til behandling af virale infektioner - Google Patents

Præparater og fremgangsmåder til behandling af virale infektioner

Info

Publication number
DK0426785T3
DK0426785T3 DK90905295T DK90905295T DK0426785T3 DK 0426785 T3 DK0426785 T3 DK 0426785T3 DK 90905295 T DK90905295 T DK 90905295T DK 90905295 T DK90905295 T DK 90905295T DK 0426785 T3 DK0426785 T3 DK 0426785T3
Authority
DK
Denmark
Prior art keywords
methods
preparations
viral infections
treating viral
agents
Prior art date
Application number
DK90905295T
Other languages
Danish (da)
English (en)
Inventor
Daniel Meruelo
Gad Lavie
Yehuda Mazur
Original Assignee
Univ New York
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York, Yeda Res & Dev filed Critical Univ New York
Application granted granted Critical
Publication of DK0426785T3 publication Critical patent/DK0426785T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK90905295T 1989-03-16 1990-03-16 Præparater og fremgangsmåder til behandling af virale infektioner DK0426785T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32417789A 1989-03-16 1989-03-16
US41716389A 1989-10-04 1989-10-04
US48851890A 1990-02-27 1990-02-27
PCT/US1990/001463 WO1990010438A1 (en) 1989-03-16 1990-03-16 Compositions and methods for treating viral infections

Publications (1)

Publication Number Publication Date
DK0426785T3 true DK0426785T3 (da) 1999-05-31

Family

ID=27406317

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90905295T DK0426785T3 (da) 1989-03-16 1990-03-16 Præparater og fremgangsmåder til behandling af virale infektioner

Country Status (11)

Country Link
US (1) US6150414A (de)
EP (1) EP0426785B1 (de)
JP (1) JPH04504849A (de)
AT (1) ATE170399T1 (de)
AU (1) AU640131B2 (de)
CA (1) CA2029863C (de)
DE (1) DE69032613T2 (de)
DK (1) DK0426785T3 (de)
ES (1) ES2123499T3 (de)
IL (1) IL93682A (de)
WO (1) WO1990010438A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018123A2 (en) * 1991-04-10 1992-10-29 Octamer, Inc. A method for inhibition of retroviral replication
US6576784B1 (en) * 1993-05-27 2003-06-10 Yeda Research And Development Co. Ltd. Antiviral agents
IL121440A0 (en) 1997-07-31 1998-01-04 Yeda Res & Dev The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
JP4776075B2 (ja) 1998-12-31 2011-09-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 改変ｈｉｖｅｎｖポリペプチド
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
WO2001056558A1 (en) * 2000-01-31 2001-08-09 Yeda Research And Development Co. Ltd. Polycyclic dianthraquinones as anti-cancer and anti-angiogenic agents
EP1411770A4 (de) 2001-07-05 2006-05-10 Chiron Corp Polynukleotide, die für antigene hiv-polypeptide des c-typs codieren, polypeptide und ihre verwendung
CA2458995C (en) 2001-08-31 2013-04-30 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
JP4076749B2 (ja) * 2001-10-15 2008-04-16 富士フイルム株式会社 導電性有機化合物及び電子素子
WO2016145279A2 (en) * 2015-03-12 2016-09-15 Stc.Unm Compositions and methods that inhibit quorum sensing
RU2719582C1 (ru) * 2016-03-01 2020-04-21 Солидженикс, Инк. Системы и способы для получения синтетического гиперицина
WO2019109046A1 (en) 2017-11-30 2019-06-06 Arrakis Therapeutics, Inc. Nucleic acid-binding photoprobes and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2707704A (en) * 1951-09-29 1955-05-03 Schenley Ind Inc Process for the preparation of hypericin
US3974186A (en) * 1970-05-14 1976-08-10 Richardson-Merrell Inc. Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4670265A (en) * 1983-07-22 1987-06-02 Sydiskis Robert J Aloe emodin and other anthraquinones and anthraquinone-like compounds from plants virucidal against herpes simplex viruses
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
IL79661A (en) * 1986-08-08 1991-01-31 Yeda Res & Dev Antiviral composition containing hypericin or pseudohypericin
US4898891A (en) * 1987-08-07 1990-02-06 Yeda Research And Development Company Ltd. Antiviral compositions
DE332679T1 (de) * 1987-08-10 1990-04-12 New York University, New York, N.Y. Antivirale zusammensetzungen mit aromatischen polycyclischen dionen sowie methode zur behandlung retroviraler infektionen.
AU3294289A (en) * 1988-03-23 1989-10-16 New York University Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections
JPH0244231A (ja) * 1988-08-04 1990-02-14 Fuji Electric Co Ltd 中和滴定装置

Also Published As

Publication number Publication date
WO1990010438A1 (en) 1990-09-20
ATE170399T1 (de) 1998-09-15
IL93682A (en) 1996-06-18
EP0426785A4 (en) 1991-11-13
US6150414A (en) 2000-11-21
DE69032613D1 (de) 1998-10-08
EP0426785B1 (de) 1998-09-02
DE69032613T2 (de) 1999-02-25
CA2029863A1 (en) 1990-09-17
AU5338790A (en) 1990-10-09
ES2123499T3 (es) 1999-01-16
CA2029863C (en) 2001-10-30
JPH04504849A (ja) 1992-08-27
EP0426785A1 (de) 1991-05-15
AU640131B2 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
DK0426785T3 (da) Præparater og fremgangsmåder til behandling af virale infektioner
EA199901031A1 (ru) Производные бензимидазола
YU74292A (sh) Jedinjenja za inhibiciju hiv i srodnih virusa
DE69331316D1 (de) Verwendung von protease-inhibitoren als antiviral agentien
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
ES2083668T5 (es) Combinaciones antiviricas que contienen analogos de nucleosido.
MX9308016A (es) Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
ES2165269A1 (es) Derivados de alfa-cetoamidas.
IT8123602A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
DK0725637T3 (da) Parenteralt busulfan til behandling af malign sygdom
ES2108969T3 (es) Utilizacion de analogos de didesoxinucleosidos en el tratamiento de infecciones virales.
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
IT8123940A0 (it) Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo.
DK10488D0 (da) Benzen-derivater med antiinflammatorisk virkning og fremgangsmaade til fremstilling deraf
ES8502097A1 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
CA2100066A1 (en) Michellamines useful as antiviral agents, composition and method of treatment
DK178188D0 (da) Antivirusmiddel
FI891665A0 (fi) Antivirala blandningar, som innehaoller aromatiska polycykliska dioner och en vaordmetod foer retrovirusinfektioner.
DK384387A (da) Erythromycin-derivater til forebyggelse og behandling af sygdomme fremkaldt af virus
PY0101564A (es) Triazine containing anionic compounds useful as antiviral agents
DK0579765T3 (da) Fremgangsmåde og præparat til behandling af herpes-relaterede sygdomme
NO960849L (no) Difluorstaton-antivirale analoger
ECSP972314A (es) Derivados de aminoacidos